Aspiration & Biopsy Needles Market Size (2024 - 2029)

Aspiration & Biopsy Needles Market Analysis

The Aspiration & Biopsy Needles Market size is estimated at USD 1.10 billion in 2024, and is expected to reach USD 1.66 billion by 2029, growing at a CAGR of 7.15% during the forecast period (2024-2029).

• The rising incidence of cancer, awareness about the disease and treatment options, patient preference for minimally invasive surgeries, rising healthcare spending, and technological advancements in image-guided biopsy systems are all driving the market forward.
• According to an article published in the Chinese Medical Journal in February 2022, an estimated 4,820,000 new cancer cases were expected in China and 2,370,000 in the United States in 2022. The most common cancers were lung cancer in China and breast cancer in the United States. The rising incidence and mortality of cancers such as breast cancer led to higher adoption of needle-based biopsy instruments for testing breast cancer, thereby indicating this market's high growth.
• Additionally, governments of different countries are taking initiatives to increase awareness about cancer and its diagnosis so that it can be detected earlier. For instance, in February 2022, the Health Minister of Tamil Nadu, a state of India, stated that the Government of Tamil Nadu is engaged in framing a policy to identify 66% of cancer patients in the first and second stages by 2030 and thus proper treatment could be availed. Hence, such policies are expected to drive the growth of the market, as it would increase the usage of biopsy needles for cancer diagnosis.
• Moreover, the market is expected to be driven by technological advancements, product launches, and merger and acquisition activity by key market players during the forecast period. For instance, in August 2022, Mammotome unveiled its groundbreaking Mammotome DualCore biopsy system, marking its debut in the dual-stage core biopsy instrument market. With its lightweight, ergonomic, and intelligent design, the device minimizes needle movements and vibrations and enhances the overall patient experience.
• Thus, the factors mentioned above are expected to drive market growth during the forecast period. However, the market is constrained by the risk of infections associated with aspiration and biopsy needles.

Aspiration & Biopsy Needles Industry Segmentation

Biopsy needles are medical instruments that are used to perform a biopsy, which is a procedure that involves obtaining a sample of cells from your body for laboratory testing. Fine-needle aspiration and core needle biopsy are two common needle biopsy procedures. Needle biopsy is a procedure that takes tissue or fluid samples from muscles, bones, and other organs like the liver and lungs.

The aspiration and biopsy needles market is segmented by product, application, procedures, end user, and geography. By products, the market is segmented as biopsy needles and aspiration needles. By application, the market is segmented as breast cancer, lung cancer, colorectal cancer, prostate cancer, wound applications, and other applications. The market is segmented by procedures, such as image-guided, ultrasound-guided, stereotactic, CT-guided procedures, MRI-guided procedures, and other procedures. By end user, the market is segmented as hospitals and surgical centers, diagnostic clinics and pathology laboratories, and other end users. By geography, the market is segmented as North America, Europe, Asia-Pacific, the Middle East and Africa, and South America). The report also covers the estimated market sizes and trends for 17 countries across major global regions.

The report offers the value (USD) for the above segments.